Efficacy of RestoreX after prostatectomy: open‐label phase of a randomised controlled trial.

Further clinical studies are necessary to better define specific patient characteristics that can predict better clinical outcomes, the optimal duration of therapy, and factors to improve patient compliance in PTT. Abbreviations ED erectile dysfunction PD Peyronie's disease PTT penile traction therapy RxPTT RestoreX PTT Penile traction therapy (PTT) has emerged as an attractive conservative treatment for Peyronie's disease (PD) and published international guidelines recommended Grade B, Level 2 Evidence regarding the use of PTT as an effective and safe treatment [[1]]. Furthermore, numerous clinical studies have shown that PTT can be an effective and safe monotherapy or as an adjunct therapy with concurrent oral or intralesional therapy, in both acute and chronic phases of PD [[8], [10]]. [Extracted from the article]